What you should know:
1. Exact expects to have the ability to process 7 million Cologuard tests by the end of 2019. Cologuard is a noninvasive screening test for colorectal cancer.
2. The newly opened lab can process 4 million tests, while Exact’s existing lab can process 3 million tests. Exact has processed more than 2 million Cologuard tests since 2014, when the test earned FDA approval.
3. The lab is on a property Exact labeled the Discovery Campus. Exact moved its customer care team into a neighboring office building and will open a large parking structure soon. A production and manufacturing space also sits on the campus.
More articles on surgery centers:
American Pain Society considers bankruptcy — 4 details
NAPA anesthesiologists win national performance accolade — 4 details
Viewpoint: How payers are suppressing anesthesia payments — 3 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.